| Name | Title | Contact Details |
|---|---|---|
Christopher Prentiss |
chief financial officer | Profile |
Dracen is a privately funded biotech company developing drugs in the area in of immuno metabolism.
Atlantic Biologicals Corporation is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Anuncia Medical, Inc., an emerging leader in Cerebrospinal Fluid (CSF) management
Esperance Pharmaceuticals, Inc. is developing a new class of targeted oncology products that selectively kill cancer cells without harming normal cells. Targeting occurs through binding to specific receptors on the cancer cell surface. The novel product candidates destroy dividing and non-dividing cancer cells including those known to be resistant to chemotherapeutics.